Department of Ophthalmology, Eberhard-Karls University Tuebingen, Tuebingen, Germany.
Cornea. 2013 Nov;32(11):1414-7. doi: 10.1097/ICO.0b013e31828321c1.
To evaluate the clinical outcome of a secondary Descemet membrane endothelial keratoplasty (DMEK) to manage graft failure after primary DMEK.
Retrospective analysis of graft failure after primary DMEK treated with a second DMEK. The clinical outcome was evaluated by comparing the pre- to postoperative best-corrected visual acuity (BCVA) after first and second DMEK.
In 122 DMEKs performed, 6 patients were included because of nonclearing edema or graft detachment. Ten of 122 grafts failed, 8 had a second DMEK, and 6 had an adequate follow-up with visual potential to be included in the visual acuity analysis. All patients had Fuchs dystrophy as the underlying disease for the endothelial decompensation. Average time to the second surgery was 2.9 months (1-5 months). Mean follow-up after second DMEK was 3.3 months (1-6 months). BCVA was 0.63 ± 0.22 logarithm of the minimum angle of resolution (logMAR) preoperatively and decreased to 1.50 ± 0.28 logMAR after first surgery (mean follow-up, 2.9 months; P < 0.001). BCVA increased to 0.13 ± 0.05 after successful second DMEK (mean follow-up, 3.3 months; P < 0.001). All second DMEKs were successful.
To manage DMEK cases with graft failure, secondary DMEK may be a feasible procedure potentially resulting in full visual rehabilitation, as in primary DMEK. In the event of a DMEK graft failure, a secondary DMEK may be an effective back-up procedure because it may give a clinical outcome similar to that given after a primary DMEK.
评估原发性 Descemet 膜内皮角膜移植术(DMEK)后因移植物失败而进行二次 DMEK 的临床结果。
对原发性 DMEK 治疗后因移植物失败而进行二次 DMEK 的病例进行回顾性分析。通过比较首次和二次 DMEK 术后最佳矫正视力(BCVA),评估临床结果。
在 122 例 DMEK 中,有 6 例患者因水肿未消退或移植物脱离而纳入研究。122 个移植物中有 10 个失败,其中 8 个进行了二次 DMEK,6 个有足够的随访时间,有潜在的视力可以进行视力分析。所有患者均为内皮失代偿的 Fuchs 营养不良。二次手术的平均时间为 2.9 个月(1-5 个月)。二次 DMEK 后平均随访时间为 3.3 个月(1-6 个月)。术前 BCVA 为 0.63±0.22 对数最小角分辨率(logMAR),首次手术后降至 1.50±0.28 logMAR(平均随访时间,2.9 个月;P<0.001)。成功进行二次 DMEK 后,BCVA 增加至 0.13±0.05(平均随访时间,3.3 个月;P<0.001)。所有二次 DMEK 均成功。
对于 DMEK 移植物失败的病例,二次 DMEK 可能是一种可行的方法,可潜在实现完全视力康复,与原发性 DMEK 相似。在发生 DMEK 移植物失败的情况下,二次 DMEK 可能是一种有效的备用手术,因为它可能会产生类似于原发性 DMEK 的临床结果。